Abstract
Over the last decade subarachnoid haemorrhage (SAH) has increasingly been recognised as a cause of hypopituitarism. We report on the case of a patient with evidence of growth hormone deficiency manifesting after a period of time, with a favourable response to growth hormone replacement. This is followed by a review of the current literature.
Acknowledgement
CG and DC are in receipt of an investigator initiated research grant from Pfizer. Study design, data collection and data analysis were performed independantly of Pfizer.
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.